UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$4.07B |
| 2 |
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
|
+$2.25B |
| 3 |
Costco
COST
|
+$252M |
| 4 |
NVIDIA
NVDA
|
+$242M |
| 5 |
Advanced Micro Devices
AMD
|
+$242M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$274M |
| 2 |
UnitedHealth
UNH
|
+$207M |
| 3 |
SPLK
Splunk Inc
SPLK
|
+$204M |
| 4 |
Home Depot
HD
|
+$203M |
| 5 |
Qualcomm
QCOM
|
+$200M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.71% |
| 2 | Healthcare | 12.08% |
| 3 | Financials | 11.18% |
| 4 | Consumer Discretionary | 10.43% |
| 5 | Communication Services | 8.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Zymeworks
ZYME
$1.67B
| $592K | ﹤0.01% |
56,301
| – | – |
|
2177
Edgewise Therapeutics
EWTX
$4.73B
| $591K | ﹤0.01% |
32,413
+8,800
| +37% | +$140K |
|
2178
Lightwave Logic
LWLG
$1.25B
| $591K | ﹤0.01% |
126,285
| – | – |
|
|
ITOS
2179
DELISTED
iTeos Therapeutics
ITOS
| $590K | ﹤0.01% |
43,255
| – | – |
|
|
OPTU
2180
Optimum Communications Inc
OPTU
$301M
| $589K | ﹤0.01% |
225,768
-37,046
| -14% | -$93.2K |
|
|
RVNC
2181
DELISTED
Revance Therapeutics, Inc.
RVNC
| $587K | ﹤0.01% |
119,361
| – | – |
|
2182
FIGS
FIGS
$2.37B
| $586K | ﹤0.01% |
117,756
-53,943
| -31% | -$310K |
|
2183
Vicor
VICR
$10.2B
| $581K | ﹤0.01% |
15,202
| – | – |
|
2184
Vita Coco
COCO
$3.6B
| $580K | ﹤0.01% |
23,735
| – | – |
|
2185
Theravance Biopharma
TBPH
$877M
| $579K | ﹤0.01% |
64,528
| – | – |
|
2186
Acco Brands
ACCO
$407M
| $578K | ﹤0.01% |
102,954
| – | – |
|
2187
DMC Global
BOOM
$157M
| $575K | ﹤0.01% |
29,499
+6,051
| +26% | +$106K |
|
|
FINV
2188
FinVolution Group
FINV
$1.15B
| $571K | ﹤0.01% |
113,344
| – | – |
|
2189
Planet Labs
PL
$8.53B
| $570K | ﹤0.01% |
223,603
| – | – |
|
2190
Taboola.com
TBLA
$1.11B
| $570K | ﹤0.01% |
128,271
| – | – |
|
|
NXDR
2191
Nextdoor Holdings
NXDR
$986M
| $569K | ﹤0.01% |
252,793
| – | – |
|
2192
Ribbon Communications
RBBN
$383M
| $567K | ﹤0.01% |
177,247
+19,684
| +12% | +$59.9K |
|
|
NVRO
2193
DELISTED
NEVRO CORP.
NVRO
| $563K | ﹤0.01% |
38,961
| – | – |
|
2194
Star Group
SGU
$423M
| $561K | ﹤0.01% |
55,938
| – | – |
|
2195
Orthofix Medical
OFIX
$419M
| $560K | ﹤0.01% |
38,594
+4,721
| +14% | +$65.3K |
|
2196
Malibu Boats
MBUU
$567M
| $559K | ﹤0.01% |
12,922
| – | – |
|
2197
Symbotic
SYM
$5.22B
| $558K | ﹤0.01% |
12,400
| – | – |
|
2198
Ivanhoe Electric
IE
$1.74B
| $556K | ﹤0.01% |
56,756
| – | – |
|
|
OLO
2199
DELISTED
Olo Inc
OLO
| $555K | ﹤0.01% |
101,166
| – | – |
|
2200
Beazer Homes USA
BZH
$907M
| $555K | ﹤0.01% |
16,916
| – | – |
|
Similar funds
UBS AM's Q1 2024 Portfolio in Review
As of Q1 2024, UBS AM held 2,593 positions worth $281B, up 11% from $254B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 4.9%. UBS AM opened 53 new positions and exited 73, leaving the 2,593-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q1 2024 buy was iShares Core MSCI EAFE ETF: 57,224,039 shares worth $4.25B.
- UBS AM added most to Costco in Q1 2024, an estimated $252M increase.
- UBS AM's biggest Q1 2024 reduction was Procter & Gamble, cutting an estimated $274M.
- UBS AM fully exited Splunk Inc in Q1 2024, selling an estimated $204M.
- UBS AM's ten largest holdings make up 27% of its $281B portfolio in Q1 2024.
- UBS AM opened 53 new positions and closed 73 in Q1 2024.
- UBS AM's portfolio value rose 11% quarter-over-quarter to $281B.
Based on UBS AM's 13F filing for Q1 2024, filed 15 May 2024.